BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16990195)

  • 1. Helicobacter pylori infection and antisecretory efficacy of proton-pump inhibitors in gastroesophageal reflux disease: a liaison dangereuse or an innocent interplay?
    Parente FR; Bargiggia SA; Anderloni A
    Scand J Gastroenterol; 2006 Oct; 41(10):1121-5. PubMed ID: 16990195
    [No Abstract]   [Full Text] [Related]  

  • 2. Review article: Helicobacter pylori and gastro-oesophageal reflux disease.
    Delaney B; McColl K
    Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():32-40. PubMed ID: 16042657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Helicobacter pylori affect the management of gastroesophageal reflux disease?
    Labenz J
    Am J Gastroenterol; 1999 Apr; 94(4):867-9. PubMed ID: 10201446
    [No Abstract]   [Full Text] [Related]  

  • 4. [GERD after H. pylori eradication therapy].
    Kinoshita Y; Adachi K; Ishihara S
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():477-82. PubMed ID: 11979831
    [No Abstract]   [Full Text] [Related]  

  • 5. Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications.
    Robinson M
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():1-10. PubMed ID: 15496213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori and omeprazole therapy in GERD.
    Kuipers EJ; Schenk BE; Klinkenberg-Knol EC; Meuwissen SG
    Am J Gastroenterol; 1999 Nov; 94(11):3378-9. PubMed ID: 10566757
    [No Abstract]   [Full Text] [Related]  

  • 7. Helicobacter pylori seropositivity predicts outcomes of acid suppression therapy for laryngopharyngeal reflux symptoms.
    Oridate N; Takeda H; Yamamoto J; Asaka M; Mesuda Y; Nishizawa N; Mori M; Furuta Y; Fukuda S
    Laryngoscope; 2006 Apr; 116(4):547-53. PubMed ID: 16585857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Should Helicobacter pylori infection be considered in patients with gastro-esophageal reflux?].
    Clavière C; Bigard MA
    Gastroenterol Clin Biol; 1999 Oct; 23(10 Pt 2):C65-78. PubMed ID: 10880916
    [No Abstract]   [Full Text] [Related]  

  • 9. Controversial topics in surgery: gastro-oesophageal reflux disease.
    Dehn T; Loft DE
    Ann R Coll Surg Engl; 2005 Jul; 87(4):233-5. PubMed ID: 16053679
    [No Abstract]   [Full Text] [Related]  

  • 10. [Helicobacter pylori and gastro-esophageal reflux disease: clinical considerations].
    Berrutti M; Fagoonee S; Astegiano M; Pellicano R; Rizzetto M
    Minerva Gastroenterol Dietol; 2007 Jun; 53(2):153-6. PubMed ID: 17557043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gastroesophageal reflux in the adult: what are the results of medical treatments? (II)].
    Zerbib F
    Gastroenterol Clin Biol; 1999 Jan; 23(1 Pt 2):S255-73. PubMed ID: 10078456
    [No Abstract]   [Full Text] [Related]  

  • 12. Antisecretory drugs, Helicobacter pylori infection and symptom relief in GORD: still an unexplored triangle.
    Scarpignato C
    Dig Liver Dis; 2005 Jul; 37(7):468-74. PubMed ID: 15893968
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of gastroesophageal reflux: should Helicobacter pylori infection be taken into account?].
    De Korwin JD
    Gastroenterol Clin Biol; 1999 Jan; 23(1 Pt 2):S121-9. PubMed ID: 10078440
    [No Abstract]   [Full Text] [Related]  

  • 14. Gastroesophageal reflux disease.
    Fernández-Fernández FJ
    N Engl J Med; 2009 Feb; 360(7):729; author reply 729-30. PubMed ID: 19222130
    [No Abstract]   [Full Text] [Related]  

  • 15. Review article: Helicobacter pylori and gastro-oesophageal reflux disease--the European perspective.
    McColl KE
    Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 8():36-9. PubMed ID: 15575871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence and adherence to proton pump inhibitors in daily clinical practice.
    Van Soest EM; Siersema PD; Dieleman JP; Sturkenboom MC; Kuipers EJ
    Aliment Pharmacol Ther; 2006 Jul; 24(2):377-85. PubMed ID: 16842465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evidence and uncertainties on the clinical use of proton pump inhibitors].
    de Prados CM
    Gastroenterol Hepatol; 2010 May; 33 Suppl 1():5-10. PubMed ID: 20728783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.
    Jensen RT
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):4-19. PubMed ID: 16433886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: the long-term use of proton-pump inhibitors.
    Raghunath AS; O'Morain C; McLoughlin RC
    Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():55-63. PubMed ID: 16042660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitors in the management of GORD and PUD.
    Kenny E
    Ir Med J; 1993; 86(4):114. PubMed ID: 8395486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.